BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that CEO Jeffrey Bailey and CFO Terry Coelho will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that CEO Jeffrey Bailey and CFO Terry Coelho will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, and the Cantor Fitzgerald Global Healthcare Conference from September 27-30. The H.C. Wainwright fireside chat will be available on-demand starting September 13 at 7:00 AM ET. The Cantor Fitzgerald presentation is scheduled for September 28 at 9:20 AM ET. Institutional investors can arrange one-on-one meetings with BDSI management through their sales representatives.
Details
News Market Reaction – BDSI
The recorded move for BDSI in the trading session of this news was -1.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Executive Vice President and Chief Financial Officer, will present and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference taking place on September 13-15 and the Cantor Fitzgerald Global Healthcare Conference taking place on September 27-30.
The fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference will be available to conference registrants on-demand beginning Monday, September 13, 2021, at 7:00 AM ET.
Details for the live presentation at the Cantor Fitzgerald Global Healthcare Conference can be found below.
| Date: | Tuesday, September 28, 2021 |
| Time: | 9:20 AM ET |
| Format: | Fireside chat |
| Webcast: | https://wsw.com/webcast/cantor12/bdsi/2064020 |
Institutional investors interested in a one-on-one meeting with BDSI management should contact their respective H.C. Wainwright or Cantor Fitzgerald institutional sales representative.
About BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.
© 2021 BioDelivery Sciences International, Inc. All rights reserved.
Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
Bob@LifeSciAdvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.